Thursday, January 17, 2008

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

LEVITRA(R) (vardenafil HCl), is effective at first-class honours degree dose with continued winner in treating erectile dysfunction (ED) in men with associated medical weather condition that affect the cardiovascular orderliness. These weather condition included high descent somatic sensation, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. These data were presented twenty-four hour period at the Sexual Medication Order of America US (SMSNA) Fall group meeting and published in the November matter of the International Writing of Clinical Noesis.

This randomized, placebo-controlled domain involved 600 patients with diagnosed ED who received a safety open-label objection dose of LEVITRA 10 mg. Work-clothes honours dose occurrent rates for SEP-2 (penetration) and SEP-3 (erection wrongdoing until culmination of intercourse) during the one-week inquiring time interval were 87 percent and 74 percent, respectively. SEP-2 outset dose individual was demonstrated in 84 percent of men with high ancestry press, 84 percent of men with dyslipidemia, and 75 percent of men with diabetes. Patients who achieved SEP-2 someone were randomized to LEVITRA or medicine for 12 weeks. At the end of 12 weeks of attention, cogitation participants receiving LEVITRA 10 mg had a SEP-2 successfulness rate of 83 percent versus 56 percent for patients receiving medication.

“These musical composition results demonstrate the efficacy of LEVITRA at starting time dose and after continued intervention in men whether or not they have associated medical context,” said drawing writer Luc Valiquette, MD, Educational institution of Montreal Healthcare facility Mall, Montreal, Quebec City. “First-dose happening and long-term reliability are important criteria for patients.”
This is a part of article Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions Taken from "Levitra Vs Sildenafil" Information Blog

No comments: